Viewing Study NCT06794450


Ignite Creation Date: 2025-12-24 @ 5:21 PM
Ignite Modification Date: 2026-01-01 @ 2:42 PM
Study NCT ID: NCT06794450
Status: RECRUITING
Last Update Posted: 2025-01-28
First Post: 2025-01-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade
Sponsor: Universitas Padjadjaran
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module